# Viva Ventures Biotech

Viva Ventures Biotech is a Venture Capital based in Cambridge, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Cambridge, United States
- **Region:** North America
- **Address:** Cambridge, MA, United States
- **Founded:** 2013
- **Assets under management:** Undisclosed
- **Website:** www.vivaventuresbiotech.com
- **LinkedIn:** https://www.linkedin.com/company/viva-ventures-biotech

## Regulatory record

- **Reports private funds:** No

## About

Founded in 2013, Viva Ventures Biotech is an early-stage life sciences investor that deploys capital into discovery-stage biotechnology companies. The firm was established in Cambridge, Massachusetts — a location that places it within one of the world's densest biotech innovation clusters — and maintains an operational history rooted in Hong Kong, according to its corporate filings. Its founding thesis centers on identifying and building companies at the earliest inflection points of drug discovery, platform biology, and therapeutic development. Viva Ventures targets seed and start-up stage investments across biotechnology, with a strategy that spans first-in-class therapeutics, enabling life-science platforms, and novel assay technologies. The firm participates primarily through direct equity investments rather than fund-of-funds structures, acting as a company-building partner from formation onward. Its geographic mandate is global, with a particular interest in trans-Pacific opportunities bridging North American innovation and Asian market access. While specific portfolio company names are not publicly catalogued, the firm's stated focus areas include oncology, rare disease, and AI-driven drug discovery. The firm does not publicly disclose assets under management or total deployment figures. No known affiliated foundations, parallel vehicles, or co-investment clubs have been identified in public records. Structurally, Viva Ventures Biotech separates itself from generalist venture firms by concentrating solely on discovery-stage biotech — a narrow mandate that demands close collaboration with academic founders and wet-lab scientists rather than the board-level governance typical of later-stage health investors.

## Sectors

- Biotech
- Digital Health

## Questions

### What investment stages does Viva Ventures Biotech target?

Viva Ventures Biotech focuses exclusively on discovery-stage and seed-stage biotechnology companies. The firm invests at the earliest inflection point of drug development — when a scientific insight is being translated into a company — rather than in pre-clinical or clinical-stage assets. Its mandate spans start-up formation through initial seed rounds.

### How does Viva Ventures Biotech source its deals?

The firm sources deals through a global network of academic institutions, research hospitals, and biotech incubators, with a particular geographic emphasis on North America and Asia. Its Cambridge location provides proximity to Harvard, MIT, and the Boston-Cambridge biotech ecosystem, which represents one of the deepest benches of discovery-stage science globally.

## Related profiles

- [Vivaris Capital](https://altss.com/profile/vivaris-capital)
- [Vives](https://altss.com/profile/vives)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/viva-ventures-biotech

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology